📇 Rhumatologue · PARIS · (75) · Libéral

MME MICHELINE MOYAL-BARRACCO

Pourquoi vous devez consulter ce praticien

2 raisons identifiées

Auteur de référence en rhumatologie
21 articles scientifiques publiés — un praticien à la pointe de la recherche
Délais de RDV courts dans la région
336.2 rhumatos / 100 000 hab. — département bien doté

Rhumatologue

📍 PARIS (75)LibéralRPPS 10000188978

📊 Reconnaissance scientifique : 18/100📝 29 articles publiés🇫🇷 Publications académiques françaises (2)

✨ Génération du profil synthétique IA en cours…

Activité de recherche & publications

Indicateurs publics agrégés sur 250 M+ d'œuvres scientifiques (OpenAlex, PubMed). Traduits ici en langage patient.

Influence scientifique

Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.

Top publications · les plus citées

The vulvodynia guideline

Journal of lower genital tract disease · 2005

📚 179 citations🎯 RCR 6.91Top 5% NIH🩺 Clinique

The clinical role of LASER for vulvar and vaginal treatments in gynecology and female urology: An ICS/ISSVD best practice consensus document

Neurourology and urodynamics · 2019

📚 51 citations🎯 RCR 4.52Top 9% NIH🔓 Open Access

Lire l'abstract Crossref ↓

BACKGROUNDThe clinical role of LASER for vulvar and vaginal treatments in gynecology and female urology is controversial.AIMSIn this best practice document, we propose recommendations for the use of LASER for gynecologic and urologic conditions such as vulvovaginal atrophy, urinary incontinence, vulvodynia, and lichen sclerosus based on a thorough literature review.MATERIALS & METHODSThis project was developed between January and September 2018. The development of this document followed the ICS White Paper Standard Operating Procedures.RESULTSMost of the available studies are limited by their design; for example they lack a control group, patients are not randomized, follow up is short term, series are small, LASER is not compared with standard treatments, and studies are industry sponsored. Due to these limitations, the level of evidence for the use of LASER in the treatment of these conditions remains low and does not allow for definitive recommendations for its use in routine clinical practice. Histological evidence is commonly reported as proof of tissue regeneration following LASER treatment. However, the histological changes noted can also be consistent with reparative changes after a thermal injury rather than necessarily representing regeneration or restoration of function. The use of LASER in women with vulvodynia or lichen sclerosus should not be recommended in routine clinical practice. There is no biological plausibility or safety data on its use on this population of women.DISCUSSIONThe available clinical studies do not present convincing data regarding the efficacy of LASER for the treatment of vaginal atrophy or urinary incontinence. Also, while short‐term complications seem to be uncommon, data concerning long‐term outcomes are lacking.CONCLUSIONAt this point, LASER is not recommended for routine treatment of the aforementioned conditions unless part of well‐designed clinical trials or with special arrangements for clinical governance, consent, and audit.

Perineoplasty for the treatment of introital stenosis related to vulvar lichen sclerosus

American journal of obstetrics and gynecology · 2002

📚 51 citations🎯 RCR 2.55Top 20% NIH

Cookies & analyse de trafic

MME MICHELINE MOYAL-BARRACCO

Pourquoi vous devez consulter ce praticien

Activité de recherche & publications

Publications académiques en France

Lieu de consultation

Tarifs & secteur de conventionnement

Prendre rendez-vous & contact

Top publications · les plus citées

Publications scientifiques (21) — classées par pathologie

Transversal15

Recommandations4

Économie santé1

Épidémiologie & registres1

Qualité de vie / PROMs1

Partager cette fiche